Defective p38 mitogen-activated protein kinase signaling impairs chemotaxic but not proliferative responses to stromal-derived factor-1α in acute lymphoblastic leukemia

被引:54
作者
Bendall, LJ
Baraz, R
Juarez, J
Shen, W
Bradstock, KF
机构
[1] Univ Sydney, Westmead Millennium Inst, Inst Canc Res, Sydney, NSW 2145, Australia
[2] Westmead Hosp, Dept Hematol, Westmead, NSW, Australia
关键词
D O I
10.1158/0008-5472.CAN-04-3402
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The chemokine stromal-derived factor-1 alpha (SDF-1 alpha) regulates leukemic cell motility and proliferation; however, the importance of these functions in the growth and dissemination of leukemia is unclear. We examined SDF-1 alpha-mediated responses of cells from 27 cases of acute lymphoblastic leukemia (ALL). Although cells from the majority of cases showed chemotactic and proliferative responses to SDF-1 alpha, a subset of cases did not undergo chemotaxis in response to SDF-1 alpha, while still demonstrating dependence on SDF-1 alpha for proliferation in stroma-supported cultures. This chemotactic defect was associated with an absence of phosphorylation ofp38 mitogen-activated protein kinase (MAPK) induced by SDF-1 alpha, and of SDF-1 alpha-induced augmentation of beta(1) integrin-mediated adhesion. Signaling through phosphoinositide 3-kinase and MEK was not affected. No correlation was observed between CXCR4 expression and chemotactic function, in vitro migration into bone marrow stromal layers, and engraftment of leukemic cells in nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice. This study suggests that signaling through p38 MAPK is required for ALL cell chemotaxis but not for proliferation, and that the loss of a chemotactic response to SDF-1 alpha does not impede engraftment in NOD/SCID mice.
引用
收藏
页码:3290 / 3298
页数:9
相关论文
共 49 条
[1]   The chemokine SDF-1 is a chemoattractant for human CD34(+) hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34(+) progenitors to peripheral blood [J].
Aiuti, A ;
Webb, IJ ;
Bleul, C ;
Springer, T ;
GutierrezRamos, JC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (01) :111-120
[2]   Good engraftment of B-cell precursor ALL in NOD-SCID mice [J].
Baersch, G ;
Mollers, T ;
Hotte, A ;
DockhornDworniczak, B ;
Rube, C ;
Ritter, J ;
Jurgens, H ;
Vormoor, J .
KLINISCHE PADIATRIE, 1997, 209 (04) :178-185
[3]   Glial and neuronal cells express functional chemokine receptor CXCR4 and its natural ligand stromal cell-derived factor 1 [J].
Bajetto, A ;
Bonavia, R ;
Barbero, S ;
Piccioli, P ;
Costa, A ;
Florio, T ;
Schettini, G .
JOURNAL OF NEUROCHEMISTRY, 1999, 73 (06) :2348-2357
[4]  
Barbero S, 2003, CANCER RES, V63, P1969
[5]  
BENDALL LJ, 1993, BLOOD, V82, P3125
[6]   A novel CD44 antibody identifies an epitope that is aberrantly expressed on acute lymphoblastic leukaemia cells [J].
Bendall, LJ ;
James, A ;
Zannettino, A ;
Simmons, PJ ;
Gottlieb, DJ ;
Bradstock, KF .
IMMUNOLOGY AND CELL BIOLOGY, 2003, 81 (04) :311-319
[7]  
BENDALL LJ, 1994, EXP HEMATOL, V22, P1252
[8]   A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1) [J].
Bleul, CC ;
Fuhlbrigge, RC ;
Casasnovas, JM ;
Aiuti, A ;
Springer, TA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (03) :1101-1109
[9]  
BRADSTOCK K, 1993, BLOOD, V82, P3437
[10]   INTERACTION OF ACUTE-LEUKEMIA CELLS WITH THE BONE-MARROW MICROENVIRONMENT - IMPLICATIONS FOR CONTROL OF MINIMAL RESIDUAL DISEASE [J].
BRADSTOCK, KF ;
GOTTLIEB, DJ .
LEUKEMIA & LYMPHOMA, 1995, 18 (1-2) :1-16